Antibacterial Activity of -Lactam Antibiotics in Experimental Meningitis Due to Streptococcus pneumoniae
- 1 April 1984
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 149 (4) , 568-574
- https://doi.org/10.1093/infdis/149.4.568
Abstract
In order to define the characteristics of the antibacterial activity of β-lactam antibiotics in the treatment of bacteria! meningitis, the relationship between cerebrospinal fluid (CSF) drug concentrations and the rate of bacterial killing was investigated for penicillin G and four new cephalosporins in an animal model of meningitis due to Streptococcus pneumoniae. All five drugs showed a significant correlation between increasing drug concentrations in CSF and increasing bactericidal rates. Minimal activity was observed in CSF at drug concentrations of approximately the broth minimal bactericidal concentration (MBC). Maximal activity occurred with CSF concentrations 10–30 times higher. In vitro tests did not reproduce the unique correlation of increasing drug concentrations and killing activity found in vivo. When evaluating new β-lactam antibiotics for the treatment of bacterial meningitis, it is reasonable to establish a minimum standard of CSF drug concentrations of ≥30 times the MBC against the infecting organism.This publication has 17 references indexed in Scilit:
- The New Beta-Lactamase-Stable CephalosporinsAnnals of Internal Medicine, 1982
- Host Defense and Antimicrobial Therapy in Adult Gram-Negative Bacillary MeningitisAnnals of Internal Medicine, 1982
- Antimicrobial Activity of Cefmenoxime (SCE-1365)Antimicrobial Agents and Chemotherapy, 1981
- Pharmacokinetics and Bacteriologic Efficacy of Moxalactam, Cefotaxime, Cefoperazone, and Rocephin in Experimental Bacterial MeningitisThe Journal of Infectious Diseases, 1981
- Diffusion of a new beta-lactam (LY 127935) into cerebrospinal fluidThe American Journal of Medicine, 1980
- ABSENCE OF DETECTABLE BACTERICIDAL AND OPSONIC ACTIVITIES IN NORMAL AND INFECTED HUMAN CEREBROSPINAL FLUIDS - REGIONAL HOST DEFENSE DEFICIENCY1980
- Comparison of Netilmicin with Gentamicin in the Therapy of Experimental Escherichia coli MeningitisAntimicrobial Agents and Chemotherapy, 1978
- Factors Influencing the Therapy of Experimental Proteus mirabilis Meningitis in RabbitsThe Journal of Infectious Diseases, 1978
- Cerebrospinal fluid immunoglobulins and complement in meningococcal meningitis.Journal of Clinical Pathology, 1977
- COMPARISON OF 4 AMINOGLYCOSIDE ANTIBIOTICS IN THERAPY OF EXPERIMENTAL ESCHERICHIA-COLI MENINGITIS1977